Stoke Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $228.3M
Liabilities Breakdown FY2023
Total Liabilities: $68.8M
Asset Breakdown
Total Assets: $228.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $191.4M | 83.8% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $5.8M | 2.6% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $31.1M | 13.6% |
Liabilities Breakdown
Total Liabilities: $68.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.7M | 2.5% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $67.1M | 97.5% |